Short answer
Tango Therapeutics, Inc. (TNGX) filed an 8-K current report with the SEC on June 4, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 90.96% shareholder participation established a quorum at the June 4, 2026 virtual annual meeting.
Tango Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 90.96% shareholder participation established a quorum at the June 4, 2026 virtual annual meeting
- Malte Peters and Mace Rothenberg elected as Class II directors through the 2029 annual meeting
- Kanishka Pothula’s resignation removed him from the ballot, with related votes excluded
- PwC ratified as independent auditor for fiscal 2026, with 131,097,992 votes supporting
- Executive compensation approved on an advisory basis, with 113,915,877 votes supporting
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tango Therapeutics, Inc. 8-K filings
Get the next TNGX 8-K as it lands
Follow TNGX for push alerts, or ask the research agent what this filing means.